Retinoblastoma
What's New
Last Posted: Jul 28, 2023
- Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients
C. Shroeder et al, EJHG, July 28, 2023 - Automatic retinoblastoma screening and surveillance using deep learning.
Ruiheng Zhang et al. Br J Cancer 2023 - Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Aleix Prat et al. Nature communications 2023 14(1) 1157 - A Multi-Thresholding-Based Discriminative Neural Classifier for Detection of Retinoblastoma Using CNN Models.
Parmod Kumar et al. BioMed research international 2023 20235803661 - Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm.
Jette J Bakhuizen et al. JAMA network open 2023 6(2) e2254157 - Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
Xu Guanghui et al. Annals of translational medicine 2022 10(16) 885 - Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function.
Dowlati Afshin et al. JCO precision oncology 2022 6e2200257 - Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit.
Escudero Adela et al. International journal of clinical oncology 2022 - Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.
Miller Alexandra M et al. Neuro-oncology 2022 - Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges.
Hsu Jocelyn Y et al. JCO precision oncology 2022 6e2100211 - Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting.
Liu Wanshan et al. Small methods 2022 6(1) e2101220 - Long-read nanopore DNA sequencing can resolve complex intragenic duplication/deletion variants, providing information to enable preimplantation genetic diagnosis.
Watson Christopher M et al. Prenatal diagnosis 2022 - Parental age and retinoblastoma-a retrospective study of demographic data and genetic analysis.
Tanwar Meghana et al. Eye (London, England) 2021 - How the germline informs the somatic landscape.
Chanock Stephen J et al. Nature genetics 2021 11 (11) 1523-1525 - Retinoblastoma genetics screening and clinical management.
Gupta Himika et al. BMC medical genomics 2021 14(1) 188 - Genetic predisposition to fetal and neonatal cancer.
Escudero A et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 Jan - A review of inherited cancer susceptibility syndromes.
Brown Gina R et al. JAAPA : official journal of the American Academy of Physician Assistants 2020 Dec 33(12) 10-16 - Clinical features and survival of Chinese children with trilateral retinoblastoma during 2006-2019: A retrospective multicenter study.
Fang Xiaolian et al. American journal of ophthalmology 2020 Oct - Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.
Fabian Ido Didi et al. The British journal of ophthalmology 2020 Sep - Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study.
Schofield D et al. Reproductive biomedicine & society online 2020 Jun 1037-45 - Parent Knowledge of Screening and Genetic Testing in Retinoblastoma.
Xiao Wei et al. Journal of ophthalmology 2020 20203839792 - Genetic testing for inherited ocular conditions in a developing country.
Zanolli Mario et al. Ophthalmic genetics 2020 Mar 1-5 - Next-Generation Technologies and Strategies for the Management of Retinoblastoma.
Gudiseva Harini V et al. Genes 2019 Dec 10(12) - [Promoting regulated gene diagnosis for retinoblastoma in clinical work].
Liang J H et al. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2019 Nov 55(11) 806-810 - Molecular targeted therapy of glioblastoma.
Le Rhun Emilie et al. Cancer treatment reviews 2019 Sep 80101896 - A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
Risi Emanuela et al. Breast cancer research and treatment 2018 Jul 170(2) 329-341 - Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.
Rocca Andrea et al. Cancer management and research 2018 103083-3099 - Local Coverage Determination (LCD): Biomarker Testing for Neuroendocrine Tumors/Neoplasms (L37851)
The U.S. Centers for Medicare & Medicaid Services - Would Routine Genomic Testing For Cancer And Heart Risk Make Economic Sense?
A Weintraub, Forbes, July 30, 2018 - CLINGEN Actionability Report for Retinoblastoma-RB1
ClinGen Actionability Working Group - Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price Elizabeth A et al. Ophthalmic genetics 2018 May 1-6 - Secondary findings from next-generation sequencing: what does actionable in childhood really mean?
Richer Julie et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jun - Preimplantation genetic diagnosis as a strategy to prevent having a child born with an heritable eye disease.
Yahalom Claudia et al. Ophthalmic genetics 2018 May 1-7 - Should You Get Genetic Testing for Cancer Risk?
American Cancer Society, Apr 3, 2018 - Knowledge, experiences and attitudes concerning genetics among retinoblastoma survivors and parents.
Hill Jessica A et al. European journal of human genetics : EJHG 2018 Jan - Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry Jesse L et al. Ophthalmic genetics 2017 Dec 1-3 - "Where Does it Come from?" Experiences Among Survivors and Parents of Children with Retinoblastoma in Kenya.
Gedleh Amal et al. Journal of genetic counseling 2017 Nov - Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists.
Skalet Alison H et al. Ophthalmology 2017 Oct - Genetic Testing in Pediatric Ophthalmology.
Verma Ishwar Chander et al. Indian journal of pediatrics 2017 Oct - A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.
Li Wenhui L et al. The Journal of molecular diagnostics : JMD 2016 Jul 18(4) 480-93 - Patient understanding of genetic information influences reproductive decision making in retinoblastoma.
Foster A et al. Clinical genetics 2017 Apr - Familial Retinoblastoma: Raised Awareness Improves Early Diagnosis and Outcome.
Al-Nawaiseh Ibrahim et al. Journal of ophthalmology 2017 20175053961 - Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
Dommering Charlotte J et al. Familial cancer 2016 Nov - Prenatal versus Postnatal Screening for Familial Retinoblastoma.
Soliman Sameh E et al. Ophthalmology 2016 Oct - Knowledge of genetics in familial retinoblastoma.
Soliman Sameh E et al. Ophthalmic genetics 2016 Jul 1-7 - Retinoblastoma
H Dimaras et al, Nature Reviews Disease Primers, August 28, 2015 - The Biology of Retinoblastoma.
Mendoza Pia R et al. Prog Mol Biol Transl Sci 2015 503-16 - About 1 out of 3 retinoblastomas is caused by a mutation (change) in the RB1 gene that is present in all the cells of the child's body.
from the American Cancer Society - Retinoblastoma Treatment - for health professionals (PDQ®)
from the National Cancer Institute - A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients.
Thirumalairaj Kannan et al. J. Hum. Genet. 2015 Jun 18. - Check out genetic conditions and tests associated with retinoblastoma
from the NIH Genetic Testing Registry - Genetic screening in patients with Retinoblastoma in Israel.
Sagi Michal et al. Fam. Cancer 2015 Mar 10. - Genetics and epigenetics of human retinoblastoma.
Benavente Claudia A et al. Annu Rev Pathol 2015 547-62 - Management of retinoblastoma: opportunities and challenges.
Bhavsar Dhiraj et al. Drug Deliv 2015 Mar 11. 1-9 - Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism.
Amitrano Sara et al. Eur. J. Hum. Genet. 2015 Feb 25. - Retinoblastoma genetics in India: From research to implementation.
Dimaras Helen et al. Indian J Ophthalmol 2015 Mar (3) 219-26 - Retinoblastoma is a rare cancer that begins in the retina of the eye
From the National Cancer Institute - Retinoblastoma: diagnosis and management- the UK perspective.
Jenkinson Helen et al. Arch. Dis. Child. 2015 May 4. - Risk definition and management strategies in retinoblastoma: current perspectives.
Ghassemi Fariba et al. Clin Ophthalmol 2015 985-94 - The RB tumor suppressor at the intersection of proliferation and immunity: Relevance to disease immune evasion and immunotherapy.
Hutcheson Jack et al. Cell Cycle 2015 Feb 25. 0
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: